i enjoyed re-reading about dr. rozenblat: Dr. S
Post# of 15624
(Total Views: 321)
Posted On: 03/13/2018 8:18:34 PM
i enjoyed re-reading about dr. rozenblat:
Dr. Sharon Rozenblat – Advisory Board Member
Dr. Sharon Rozenblat is tasked with overseeing the completion of the pre-clinical safety studies on the Company’s treatment for psoriasis, which commenced in November 2016. Dr. Rozenblat will also steer the Company’s efforts to commercialize its cannabis-based formulations and delivery mechanisms.
Ms. Rozenblat earned her Ph.D. in biochemistry and cell biology (Magna Cum Laude) from Bar-Ilan University in Israel. Her research focused on botanical components for Melanoma (skin cancer) treatment. From 2007 to 2015, Dr. Rozenblat served as Chief Scientist at Kamedis ltd., an Israeli-based dermatological company, where she had established and managed the research and development of herbal products for the treatment of dermatological conditions.
Dr. Rozenblat was also the Scientific Director for the development of herbal extraction in a joint venture with Green Mountain Biotech (GMB), in Chengdu, China, where she worked with GMB to find agricultural resources, develop extraction methods, establish quality control methodologies, and conduct safety and efficacy studies.
Dr. Rozenblat serves as a consultant to international organizations, including as Scientific Research Director of joint development projects funded by the Korea-Israel Industrial Research and Development Foundation (KORIL), and the Israel-Singapore Foundation (SIIRD), both of which resulted in numerous products and patents.
OWCP has a great team and will do well long term, as has been stated by me and others multiple times...yet, it is good to re-read the credentials again of all their team including Hirsch's great record, and the new cso as well...
let's face it-there are flippers, swing traders and longs... i am long on owcp..i hope the bashers/liars on another site can sleep at night-but mental cases usually don't... just had to vent a little...
Dr. Sharon Rozenblat – Advisory Board Member
Dr. Sharon Rozenblat is tasked with overseeing the completion of the pre-clinical safety studies on the Company’s treatment for psoriasis, which commenced in November 2016. Dr. Rozenblat will also steer the Company’s efforts to commercialize its cannabis-based formulations and delivery mechanisms.
Ms. Rozenblat earned her Ph.D. in biochemistry and cell biology (Magna Cum Laude) from Bar-Ilan University in Israel. Her research focused on botanical components for Melanoma (skin cancer) treatment. From 2007 to 2015, Dr. Rozenblat served as Chief Scientist at Kamedis ltd., an Israeli-based dermatological company, where she had established and managed the research and development of herbal products for the treatment of dermatological conditions.
Dr. Rozenblat was also the Scientific Director for the development of herbal extraction in a joint venture with Green Mountain Biotech (GMB), in Chengdu, China, where she worked with GMB to find agricultural resources, develop extraction methods, establish quality control methodologies, and conduct safety and efficacy studies.
Dr. Rozenblat serves as a consultant to international organizations, including as Scientific Research Director of joint development projects funded by the Korea-Israel Industrial Research and Development Foundation (KORIL), and the Israel-Singapore Foundation (SIIRD), both of which resulted in numerous products and patents.
OWCP has a great team and will do well long term, as has been stated by me and others multiple times...yet, it is good to re-read the credentials again of all their team including Hirsch's great record, and the new cso as well...
let's face it-there are flippers, swing traders and longs... i am long on owcp..i hope the bashers/liars on another site can sleep at night-but mental cases usually don't... just had to vent a little...
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼